Therapeutic proteins in cardiovascular disease

Thrombopoietin (TPO) is a humoral growth factor that does not induce platelet aggregation per se, but triggers platelet activation in response to several agonists. Experimentally, researchers have demonstrated that TPO may enhance platelet activation in the early stages of unstable angina (UA) and may be involved in the pathogenesis of acute coronary syndromes.

This is an exciting study, and studies such as this one are not uncommon to report, so Creative BioMart offers researchers a recombinant human TPO to help you better investigate the relevance of TPO to acute coronary syndromes. Of course, this is just one aspect of our diverse therapeutic protein portfolio, and we have a large number of therapeutic proteins that can be used in cardiovascular disease research.

Because of the many years of research that have demonstrated the relevance of therapeutic proteins to cardiovascular disease, Creative BioMart is committed to providing researchers in this field with a diverse range of high-quality therapeutic protein products from a variety of sources and types. We believe that our therapeutic proteins can assist you in your research, whether it is in the development of drug targets or the investigation of pathogenesis. If you do not find the product you are looking for in this list, you can submit your request to our staff and we will be available 24/7 to answer your questions or assist you in purchasing the therapeutic protein product you are looking for.

Therapeutic proteins in cardiovascular disease